An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Cell and gene therapies can be life-changing for patients with certain conditions, but the process of receiving them poses barriers for patients and caregivers that require multistakeholder solutions, ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Two months after Allogene abandoned plans for its CAR-T in leukemia, analysts have suggested that fresh phase 1 data in ...

Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...